Woodline Partners’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.1M | Sell |
|
|||||
|
2025
Q2 | $18M | Sell |
|
|||||
|
2025
Q1 | $25.6M | Buy |
|
|||||
|
2024
Q4 | $25.2M | Buy |
|
|||||
|
2024
Q3 | $31.1M | Buy |
|
|||||
|
2024
Q2 | $26.4M | Buy |
|
|||||
|
2024
Q1 | $15M | Buy |
|
|||||
|
2023
Q4 | $526K | Hold |
|
|||||
|
2023
Q3 | $371K | Hold |
|
|||||
|
2023
Q2 | $645K | Hold |
|
|||||
|
2023
Q1 | $892K | Hold |
|
|||||
|
2022
Q4 | $1.29M | Buy |
|
|||||
|
2022
Q3 | $622K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $3.04M | Hold |
|
|||||
|
2021
Q3 | $3.15M | Hold |
|
|||||
|
2021
Q2 | $3.16M | Hold |
|
|||||
|
2021
Q1 | $2.79M | Hold |
|
|||||
|
2020
Q4 | $3.27M | Sell |
|
|||||
|
2020
Q3 | $4.87M | Buy |
|
|||||
|
2020
Q2 | $3.53M | Buy |
|